UK MHRA pilot project on risk-based approach delayed
This article was originally published in SRA
Executive Summary
The UK Medicines and Healthcare products Regulatory Agency's proposed pilot project on assessing the use of a risk-based approach for authorising clinical trials has been delayed by the agency's move to new offices1. The project will now be launched in early 2011.